Replies to post #18043 on Cel Sci Corporation (CVM)

[alexander77]

Thank you. We can all agree that $1-2.9b is too low and $20-32b is too high. Should be somewhere in between for a buyout. I would be happy with $10b (including the production facility, LEAPS and all patents, including potential of Multikine for a lot of other cancer and I mean A LOT OF OTHER CANCERS)